ASCEND

Welcome to the Brand page for “ASCEND”, which is offered here for Publication of texts, books, and magazines featuring the results of clinical trials for pharmaceutical preparations in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and a1p1 deficiency and emphysema; publication of printed matter relating to the results of clinical trials for pharmaceutical preparations for the treatment of a1p1 deficiency and emphysema;the mark consists of the greek symbol alpha followed by the word ascend.;pharmaceutical preparations for inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and a1p1 deficiency and emphysema;alpha ascend;color is not claimed as a feature of the mark.;providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies. and a1p1 deficiency and emphysema;.

Its status is currently believed to be active. Its class is unavailable. “ASCEND” is believed to be currently owned by “CSL BEHRING L.L.C.”